Acute toxicity of radiochemotherapy in rectal cancer patients: A risk particularly for carriers of the TGFB1 Pro25 variant

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 149-157

  Schirmer, Markus Anton ^a   Mergler, Caroline Patricia Nadine ^a   Rave Fränk, Margret ^a   Herrmann, Markus Karl ^a   Hennies, Steffen ^a   Gaedcke, Jochen ^a   Conradi, Lena Christin ^a   Jo, Peter ^a   Beissbarth, Tim ^a   Hess, Clemens Friedrich ^a   Becker, Heinz ^a   Ghadimi, Michael ^a   Brockmöller, Jürgen ^a   Christiansen, Hans ^a   Wolff, Hendrik Andreas ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Acute toxicity; Polymorphism; Radiochemotherapy; Rectal cancer; TGFB1

Indexed keywords

ACUTE TOXICITY; ADVERSE EVENTS; BODY MASS INDEX; CLINICAL CARE; CLINICAL TRIAL; COMMON TERMINOLOGY CRITERIA; DISEASE STATE; GENETIC DIVERSITY; GENETIC VARIABILITY; GERMLINE; MULTIVARIATE LOGISTIC REGRESSIONS; NEOADJUVANT RADIATION; POSITIVE PREDICTIVE VALUES; RADIOCHEMOTHERAPY; RECTAL CANCER; SIGNIFICANT IMPACTS; TGFB1; TRANSFORMING GROWTH;

CHEMOTHERAPY; DISEASES; GENES; LOGISTICS; POLYMORPHISM; REGRESSION ANALYSIS; TOXICITY;

CHEMORADIOTHERAPY;

ARGININE; FLUOROURACIL; OXALIPLATIN; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CANCER STAGING; CHEMORADIOTHERAPY; CYSTITIS; ENTERITIS; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCTITIS; QUALITY OF LIFE; RADIATION DOSE; RECTUM CANCER; SKIN MANIFESTATION; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; COHORT STUDIES; CYSTITIS; DERMATITIS; ENTERITIS; FEMALE; FLUOROURACIL; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; ORGANS AT RISK; POLYMORPHISM, SINGLE NUCLEOTIDE; PROCTITIS; PYRIDINES; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; REGRESSION ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; URINARY BLADDER;

EID: 84859844415     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.063     Document Type: Article

References (37)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. D. Sebag-Montefiore, R.J. Stephens, and R. Steele Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial Lancet 373 2009 811 820
4. C. Rodel, and R. Sauer Integration of novel agents into combined-modality treatment for rectal cancer patients Strahlenther Onkol 183 2007 227 235
5. C. Aschele, M.L. Friso, and S. Pucciarelli A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 2005 1140 1146
6. J.P. Machiels, L. Duck, and B. Honhon Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study Ann Oncol 16 2005 1898 1905
7. M. Martin, J. Lefaix, and S. Delanian TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47 2000 277 290
8. K. Randall, and J.E. Coggle Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation Int J Radiat Biol 70 1996 351 360
9. J. Wang, H. Zheng, and C.C. Sung Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy Am J Pathol 153 1998 1531 1540
10. F. Milliat, J.C. Sabourin, and G. Tarlet Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy Am J Pathol 172 2008 691 701
11. V. Haydont, B.L. Riser, and J. Aigueperse Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: A role for CCN2 and low concentration of TGF-beta1 Am J Physiol Cell Physiol 294 2008 C1332 C1341
12. K. De Jaeger, Y. Seppenwoolde, and H.H. Kampinga Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1378 1387
13. A. Novakova-Jiresova, M.M. Van Gameren, and R.P. Coppes Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients Radiother Oncol 71 2004 183 189
14. L. Zhao, K. Sheldon, and M. Chen The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer Lung Cancer 59 2008 232 239
15. D.J. Grainger, K. Heathcote, and M. Chiano Genetic control of the circulating concentration of transforming growth factor type beta1 Hum Mol Genet 8 1999 93 97
16. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity - Are we on the right track? Radiother Oncol 97 2010 1 8
17. J. Chavaudra [Last ICRU recommendations for the prescription, recording and reporting of external bean therapy] Cancer Radiother 2 1998 607 614
18. C. Rodel, T. Liersch, and R.M. Hermann Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer J Clin Oncol 25 2007 110 117
19. A. Trotti, R. Byhardt, and J. Stetz Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
20. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
21. Nagtegaal ID, van de Velde CJ, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.
22. Agresti A. Categorical data analysis. In: Loglinear models for contingency tables. Series Editor: Steve Quigley. New York: John Wiley and Sons; 1990. p. 314-356.
23. J.F. Bosset, G. Calais, and A. Daban Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group Eur J Cancer 40 2004 219 224
24. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
25. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study Radiother Oncol 97 2010 9 14
26. G. Giotopoulos, R.P. Symonds, and K. Foweraker The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes Br J Cancer 96 2007 1001 1007
27. X. Yuan, Z. Liao, and Z. Liu Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy J Clin Oncol 27 2009 3370 3378
28. M.R. Awad, A. El-Gamel, and P. Hasleton Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation Transplantation 66 1998 1014 1020
29. M.S. Khalil, A.M. El Nahas, and A.I. Blakemore Transforming growth factor-beta1 SNPs: Genetic and phenotypic correlations in progressive kidney insufficiency Nephron Exp Nephrol 101 2005 e31 e41
30. C.H. Osterreicher, C. Datz, and F. Stickel TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis Cytokine 31 2005 142 148
31. M. Rao, D. Guo, and B.L. Jaber Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients Kidney Int 66 2004 419 427
32. J. van de Wetering, C.H. Weimar, and A.H. Balk The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation Transplantation 82 2006 1744 1748
33. C.G. Densem, I.V. Hutchinson, and N. Yonan Donor and recipient- transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease Transpl Immunol 13 2004 211 217
34. E. Ogawa, J. Ruan, and J.E. Connett Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers Respir Med 101 2007 938 943
35. C.H. Osterreicher, J. Halangk, and T. Berg Evaluation of the transforming growth factor beta1 codon 25 (Arg→Pro) polymorphism in alcoholic liver disease Cytokine 42 2008 18 23
36. C.A. Peters, R.G. Stock, and J.A. Cesaretti TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy Int J Radiat Oncol Biol Phys 70 2008 752 759
37. Z. Guo, U. Binswanger, and A. Knoflach Role of codon 10 and codon 25 polymorphisms on TGF-beta 1 gene expression and protein synthesis in stable renal allograft recipients Transplant Proc 34 2002 2904 2906